Endogenous Aspergillus endophthalmitis in drug abusers

Arch Ophthalmol. 1980 May;98(5):859-62. doi: 10.1001/archopht.1980.01020030853010.

Abstract

One of two cases of endogenous Aspergillus endophthalmitis in abusers of intravenously administered drugs was treated successfully by subtotal pars plana vitrectomy; amphotericin B administered by intravitreal, periocular, and systemic routes; and flucytosine administered systemically. Aspergillus sp should be considered a possible pathogenic organism in drug abusers with endogenous endophthalmitis. An aggressive diagnostic and therapeutic approach may result in preservation of useful vision.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Amphotericin B / administration & dosage
  • Aspergillosis / diagnosis*
  • Aspergillosis / drug therapy
  • Aspergillosis / microbiology
  • Endophthalmitis / drug therapy
  • Endophthalmitis / etiology*
  • Endophthalmitis / microbiology
  • Female
  • Flucytosine / therapeutic use
  • Humans
  • Microbiological Techniques
  • Substance-Related Disorders / complications*
  • Visual Acuity
  • Vitreous Body / surgery

Substances

  • Amphotericin B
  • Flucytosine